Pancreatic Leaks and Fistulae: Pathophysiological Principles
Journal Title: Pancreas – Open Journal - Year 2018, Vol 2, Issue 1
Abstract
Pancreatic fistula is one of the common complications that may arises after upper gastrointestinal surgery, acute pancreatitis and, more rarely, abdominal traumas. The treatment is mainly based on conservative therapy. However, for persistent ones, endoscopical management is now-a-days considered as the surgical one. In this brief discussion, we want to focus the pathophysiological bases of endoscopic treatment for pancreatic leaks and fistulas.
Authors and Affiliations
Lorenzo Dioscoridi
Keywords
Related Articles
- EP ID EP556734
- DOI 10.17140/POJ-2-e006
- Views 169
- Downloads 0
Delayed Onset Post-ERCP Pancreatitis (DOPE-P)
Post Endoscopic retrograde cholangiopancreatography (ERCP) Pancreatitis (PEP) is defined as new onset or worsening of pain abdomen after ERCP with an elevation of pancreatic enzymes (amylase/lipase) more than 3 times upp...
Pancreas: Do All Roads Lead to Mitochondria?
Over several millions of years of evolution, mitochondria have transformed into specialized organelles. Today, they cannot live outside the cell nor can the host cell live without them, resulting in a symbiotic relations...
PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?
Programmed cell death protein 1 (PD-1), a member of the CD28 family, is an immune-checkpoint receptor expressed on a variety of immune cells, such as T-cells, monocytes, B-cells, dendritic cells, and tumor-infiltrating l...
Eus-Pancreaticogastrostomy in a Patient with Subtotal Gastrectomy and Roux-En-Y Reconstruction
Chronic Pancreatitis (CP) is often associated with pain due to pancreatic duct obstruction. In these patients, surgical drainage was more effective than endoscopic treatment, achieving a faster, effective, and sustained...
Epigenetic Alterations in Pancreatic Cancer
Pancreatic cancer is the fourth leading cause of cancer death and is predicted to be the second leading cause in a decade in the US. Despite more than 50 years of research and therapeutic development, pancreatic cancer s...